Aclaris Therapeutics
ACRS
ACRS
104 hedge funds and large institutions have $737M invested in Aclaris Therapeutics in 2017 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 54 increasing their positions, 24 reducing their positions, and 12 closing their positions.
Holders
104
Holders Change
–
Holders Change %
0%
% of All Funds
2.6%
Holding in Top 10
3
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-40%
% of All Funds
0.07%
New
12
Increased
54
Reduced
24
Closed
12
Calls
$4.24M
Puts
$354K
Net Calls
+$3.88M
Net Calls Change
+$81K
Top Buyers
1 |
DM
1
Deerfield Management
New York
|
$40.7M |
2 |
2
BlackRock
New York
|
$44.1M |
3 |
3
Vanguard Group
Malvern,
Pennsylvania
|
$30.6M |
4 |
FCMI
4
Foresite Capital Management III
Larkspur,
California
|
$6.79M |
5 |
![]()
5
Fidelity Investments
Boston,
Massachusetts
|
$55.6M |